Napredna pretraga

Pregled bibliografske jedinice broj: 407601

In Silico Prediction of Potential Functional and Structural Effects of Novel BRCA1 and BRCA2 Unclassified Sequence Variants Found in Healthy Females in Croatia


Ozretić, Petar; Levačić Cvok, Mirela; Musani, Vesna; Čretnik, Maja; Levanat, Sonja
In Silico Prediction of Potential Functional and Structural Effects of Novel BRCA1 and BRCA2 Unclassified Sequence Variants Found in Healthy Females in Croatia // Book of Abstracts of the HDBMB2008 / Strelec, Ivica ; Glavaš-Obrovac, Ljubica (ur.).
Zagreb: Croatian Society of Biochemistry and Molecular Biology, 2008. str. 118-118 (poster, nije recenziran, sažetak, znanstveni)


Naslov
In Silico Prediction of Potential Functional and Structural Effects of Novel BRCA1 and BRCA2 Unclassified Sequence Variants Found in Healthy Females in Croatia

Autori
Ozretić, Petar ; Levačić Cvok, Mirela ; Musani, Vesna ; Čretnik, Maja ; Levanat, Sonja

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Book of Abstracts of the HDBMB2008 / Strelec, Ivica ; Glavaš-Obrovac, Ljubica - Zagreb : Croatian Society of Biochemistry and Molecular Biology, 2008, 118-118

ISBN
978-953-95551-2-0

Skup
Kongres Hrvatskog društva za biokemiju i molekularnu biologiju - HDBMB2008

Mjesto i datum
Osijek, Hrvatska, 17.-20.09.2008

Vrsta sudjelovanja
Poster

Vrsta recenzije
Nije recenziran

Ključne riječi
BRCA1; BRCA2; in silico; UVs; mutations; polymorphisms; Croatia

Sažetak
BRCA1 (breast cancer 1 gene) and BRCA2 (breast cancer 2 gene) are the major hereditary breast/ovarian cancer predisposing genes and their mutations increase the risk of developing cancer. At present, almost half of all BRCA1 and BRCA2 sequence variants found are unclassified variants (UVs) so their clinical significance is unknown or uncertain. Interpretation of UVs is the major concern for BRCA genes, especially for risk assessment in genetic counseling. We have developed method (for the first time in Croatia) for detection of inherited predisposition to breast/ovarian cancer. We analyzed distribution and occurrence of all sequence variants in BRCA1 and BRCA2 genes on 200 healthy women in Croatia (more than 70 years old without any cancer affected family members). Those results could help us in assessing preliminary clinical significance of UVs once found in patients. The aim of this study is to predict the potential functional and structural effects of UVs using in silico methods. We used different publicly available web-based tools to identify UVs that may have deleterious effects with respect to different biomolecular functional categories (i.e. intronic and exonic splicing regulation, nonsynonymous amino acid SNP effect, interspecific amino acid conservation, belonging to known functional domain) so their clinical significance in cancer etiology could be assumed. Using straightforward physical and comparative considerations, we have found that two sequence variants with nonsynonymous amino acid changes and one amino acid deletion could have no impact on the structure and function of a BRCA1 and BRCA2 proteins. Two synonymous amino acid changes (silent mutations) could have impact on splicing regulation by disrupting and creating one exonic splicing enhancers. Our only intronic UV showed no potential impact on splicing because nucleotide changes at that position likely make no changes in consensus splice sites. All other exonic UVs do not lead to creation of potential cryptic splice sites. Predicting potential functional and structural effects of BRCA1 and BRCA2 UVs using in silico methods presents fast, easy and cheap method for assessing their preliminary clinical significance, especially in cases with low frequent and ethnic specific alleles, when it is difficult to make population based studies and when expensive in vitro functional assays must be performed.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekt / tema
098-0982464-2461 - Prijenos signala u tumorima: Hh-Gli put, interakcije i potencijalne terapije (Sonja Levanat, )

Ustanove
Institut "Ruđer Bošković", Zagreb